Jill Wechsler

Jill Wechsler is ACT's Washington Editor


Medicare Limits Aduhelm Coverage to Patients in Clinical Trials

January 12, 2022

In a highly unusual decision for a therapy approved by FDA, CMS has taken action to limit prescribing and use of Biogen’s new and controversial Alzheimer’s treatment Aduhelm.

FDA Keeps New Drugs Coming

January 05, 2022

New therapies were approved at a steady pace in 2021.

Here Come the COVID Treatment Options

December 27, 2021

Pfizer’s Paxlovid has gained emergency use authorization at a time when the U.S. is being devastated by the spreading Omicron variant.

FDA Caught In Abortion Battles

December 17, 2021

FDA has become embroiled in the debate over access to “chemical” or “medication” abortions through the prescribing and distribution of the abortifacient, mifepristone.

Califf Gains Bipartisan Support for FDA Confirmation

December 15, 2021

The Biden administration’s choice to lead FDA successfully navigated a Senate confirmation hearing on Dec. 14, setting the stage for full Senate approval early next year.